MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    An AAV9 encoding human ABCD1 (SBT101) shows functional improvement following spinal cord delivery in a rodent model of adrenomyeloneuropathy

    A. Pujol, A. Bosch, I. Dijkstra, S. Kemp, Y. Jaspers, S. Verdés, S. Fourcade, C. Guilera, M. Leal-Julià, A. Onieva, V. Vasireddy, SW. Clark, D. Anderson, K. Kozarsky (Barcelona, Spain)

    Objective: SBT101 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy candidate delivering a functional copy of the human ABCD1 gene that is in development…
  • 2022 International Congress

    The noradrenergic basis of Parkinson’s tremor

    A. Heide, M. Wessel, D. Papadopetraki, D. Geurts, T. van Prooije, F. Gommans, R. Helmich (Nijmegen, Netherlands)

    Objective: Study the effect of propranolol on (stress-related increase in) tremor power and on tremor-related activity in the cerebello-thalamo-cortical (CTC) circuit in Parkinson’s (PD) patients.…
  • 2022 International Congress

    Attending to Compensatory Strategies during Prolonged Walking in Parkinson Disease: A Pilot Study

    G. Yogev-Seligmann, M. Kafri (Haifa, Israel)

    Objective: 1. to compare the effects of compensatory strategies on the duration of attentive engagement during 10 min. walking, 2. to test associations between person's…
  • 2022 International Congress

    Synaptic Zn2+ Contribution to Parkinson’s Disease Pathophysiology: Pharmacological & Genetic Studies in Preclinical Mouse Models

    AM. Ouagazzal, J. Sikora (Marseille, France)

    Objective: The potential involvement of synaptic Zn2+ in development of Parkinson’s disease (PD) motor symptoms and dopaminergic neurodegeneration was investigated. Background: The progressive degeneration of…
  • 2022 International Congress

    No evidence for the impact of SNCA rs356219 on Parkinson’s disease progression

    A. Szwedo, T. Stoker, M. Camacho, D. Backström, L. Forsgren, R. Lawson, A. Yarnall, C. Williams-Gray, A. Macleod, C. Counsell, OB. Tysnes, G. Alves, J. Maple-Grødem (Stavanger, Norway)

    Objective: To replicate findings from previous studies reporting an association between the α-synuclein (SNCA) rs356219 genetic variant and progression to key outcomes in Parkinson’s disease…
  • 2022 International Congress

    The START Study: A Phase 4 Study on the Real-World Utilization of Deutetrabenazine Initiated by a 4-Week Patient Titration Kit

    K. Anderson, M. Konings, S. Finkbeiner, A. Cutler (Washington, USA)

    Objective: To assess the real-world utilization of deutetrabenazine (DTBZ) for the treatment of tardive dyskinesia (TD) or chorea associated with Huntington disease (HD) initiated by…
  • 2022 International Congress

    Cortico-cortical connectivity is normalised by levodopa in tremor-dominant Parkinson’s disease

    BK. Rurak, JP. Rodrigues, BD. Power, PD. Drummond, AM. Vallence (Murdoch, Australia)

    Objective: The aim of this study was to examine whether connectivity between the supplementary motor area and primary motor cortex (SMA-M1) is implicated in Parkinson’s…
  • 2022 International Congress

    Ping Pong as a sport-based intervention to increase physical activity in people with Parkinson’s Disease

    J. Domingos, J. Fernandes, J. Dean, C. Godinho (Monte de Caparica, Portugal)

    Objective: The aim of the study was to assess participant’s experiences, satisfaction, and safety of a sport-based intervention (Ping pong combined with PD-specific exercise). Background:…
  • 2022 International Congress

    The East London Parkinson Disease Project – engaging a diverse population in research

    A. Zirra, A. Ben-Joseph, T. Haque, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Noyce (London, United Kingdom)

    Objective: The objective of this study was to engage a diverse group of people with Parkinson disease (PwP) from East London and build a research…
  • 2022 International Congress

    Subthalamic beta bursts reflect the continuous stochastic fluctuations of ongoing oscillations in Parkinson’s disease

    J. Pardo-Valencia, C. Fernández-García, F. Alonso-Frech, G. Foffani (Móstoles, Spain)

    Objective: To test whether subthalamic beta bursts in Parkinson’s disease reflect the continuous stochastic fluctuations of an oscillatory random process. Background: Subthalamic beta oscillations in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley